An employee, agent, or other individual described in § 23-6.4-4 must complete an anaphylaxis training program prior to providing or administering an epinephrine auto-injector made available by an authorized entity. Such training shall be conducted by a nationally recognized organization experienced in training laypersons in emergency health treatment, or an entity or individual approved by the department of health. Training may be conducted online or in person and, at a minimum, shall cover:

(1)  Techniques on how to recognize symptoms of severe allergic reactions, including anaphylaxis;

(2)  Standards and procedures for the storage and administration of an epinephrine auto-injector; and

(3)  Emergency follow-up procedures.

Terms Used In Rhode Island General Laws 23-6.4-6

  • Authorized entity: means any entity or organization at, or in connection with, where allergens capable of causing anaphylaxis may be present, as identified by the department of health. See Rhode Island General Laws 23-6.4-1
  • Epinephrine auto-injector: means a single-use device used for the automatic injection of a premeasured dose of epinephrine into the human body. See Rhode Island General Laws 23-6.4-1
  • person: may be construed to extend to and include co-partnerships and bodies corporate and politic. See Rhode Island General Laws 43-3-6

The entity that conducts the training shall issue a certificate, on a form developed or approved by the department of health, to each person who successfully completes the anaphylaxis training program.

History of Section.
P.L. 2014, ch. 514, § 1; P.L. 2016, ch. 512, art. 1, § 11.